Work

Impact of maternal antibody-mediated protection against coxsackie B infections in early life

Year: 2025
Type: dissertation
Abstract: Enterovirus (EV), and especially coxsackievirus B (CVB), infections can be severe or even fatal for newborns and infants.CVB infections have also been proposed to be one of the main environmental triggers of type 1 diabetes (T1D).To address the relationship between the increasing T1D incidence and the declined EV infection rates in Finland, the "polio hypothesis" was proposed in 2000, based on the observation that higher paralytic poliomyelitis frequency was associated with lower rate of polio infections in the population.With an analogy, the hypothesis proposes that as mothers have encountered less EV infections in Finland, and there is no EV vaccine available, they cannot provide maternal antibodies against EVs for the offspring.Furthermore, children have infections later in life and are not protected by maternal antibodies anymore at the time of infection as the maternal antibody protection wanes during the first year of life.Thus, this could lead to increased T1D incidence in the population through impaired protection against CVB infections.This thesis aimed to study the frequency of CVB infections and maternal neutralizing antibodies against five CVB serotypes (CVB1-CVB5) in Finland.Also, the aim was to investigate if, and for how long, the maternal antibodies protect the child from CVB infections.In that regard, it was also important to determine the age of first CVB infections.Serum samples from 528 children at 4 different timepoints (cord blood, 3, 6, 12, months) were tested for neutralizing antibodies.The blood samples and clinical health records utilized in this thesis have been collected as part of the Finnish Type 1 Diabetes Prediction and Prevention (DIPP) study.The longitudinal dataset from DIPP study provided a unique opportunity to study the kinetics of eliminating maternal antibodies and determine how long maternal antibodies are present in child's blood circulation.Thus, the waning of maternal antibodies and the antibody responses in natural infections, that occurred during the first year of life, were analyzed.The key findings of this thesis implied that in Finland, among the children that have genetic risk for T1D, around 50-75% of the children did not have the maternal antibody protection against CVB at the time of birth.Maternal antibodies against CVB1 were less common than against CVB2-CVB5.CVB1 and CVB2 infections were frequent already during the first year of life, in contrast, CVB3, CVB4, and CVB5 infections were less frequent and acquired later, closer to the age of 12 months.Maternal CVB antibodies seemed to provide effective protection against early life CVB infections.The results of the kinetics of maternal antibody waning provided further evidence that transplacental passive immunity wanes during the first year of life, thus, the maternal antibodies alone are insufficient for sustained protection.These findings support the rationale for developing a vaccine that can induce neutralizing antibodies against CVB and administering the vaccine early in infancy to prevent the first CVB infections.
Language: English
Subfield: Genetics
Open Access status: green
OpenAlex ID: W7132879459
Cites: 45
Cited by:
Related to: 10